Moderated by: Andrea Peloso & Mark Ghobrial

Exposure to Semaglutide Is Associated with Decreased Progression to Liver Transplant in People with Alcohol Use Disorder
Zoe Hahn

Bridging Global Gaps in Liver Transplant Outcome Prediction According to Donor and Recipient Factors and Risk-Mitigation Strategies: The Global Improvement Study
Elisa Schirra

MELD 3.0 Demonstrates Improved Discrimination for Organ Allocation in Alcohol-Associated Liver (ALD) Diseases but Not Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) or Hepatitis C (HCV)
Mark Muthiah

Validation of Ontario Criteria for Patients Transplanted with Hepatocellular Carcinoma and Proposal of Revised Criteria
Christian Tibor Josef Magyar

Donor Serum FMN Reflects Mitochondrial Injury and Predicts Outcomes After Liver Transplantation: A Metabolic Donor Signature of Graft Quality
Fatma Selin Yildirim

Assessing Durability of Diet and Lifestyle-Based Weight Loss Interventions in Living Liver Donors After Donation in a U.S.-Based High-Volume Living Donor Liver Transplant Program
Hyosun Han